PT Dharma Polimetal Tbk (DRMA.JK)
IDR 920.0
(0.55%)
IDR 920.0
(0.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5541.17 Billion | 3905.41 Billion | 2913.26 Billion | 1874.63 Billion | 2729.39 Billion | 2452.4 Billion |
| Cost of Revenue | 4577.81 Billion | 3291.41 Billion | 2461.25 Billion | 1653.65 Billion | 2277.62 Billion | 2085.11 Billion |
| Gross Profit | 963.35 Billion | 614 Billion | 452 Billion | 220.98 Billion | 451.76 Billion | 367.28 Billion |
| Operating Expenses | 156.76 Billion | 177.7 Billion | 146.48 Billion | 157.74 Billion | 181.67 Billion | 156.21 Billion |
| Selling, General and Administrative Expenses | 320.46 Billion | 59.6 Billion | 46.77 Billion | 37.82 Billion | 52.4 Billion | 48.54 Billion |
| Research and Development Expenses | - | - | - | - | 2.63 Billion | 1.26 Billion |
| Other Expenses | -163.69 Billion | 118.09 Billion | 99.71 Billion | 119.92 Billion | 129.26 Billion | 107.66 Billion |
| Cost and Expenses | 4738.75 Billion | 3469.11 Billion | 2607.73 Billion | 1811.4 Billion | 2459.29 Billion | 2241.32 Billion |
| Operating Income | 802.41 Billion | 533.25 Billion | 309.92 Billion | 67.42 Billion | 280.28 Billion | 215.66 Billion |
| Interest Expense | 40.91 Billion | 43.12 Billion | 53.58 Billion | 53.65 Billion | 48.94 Billion | 49 Billion |
| Income Tax Expense | 143.55 Billion | 97.49 Billion | 62.59 Billion | 8.04 Billion | 58.95 Billion | 44.33 Billion |
| Earnings before Tax | 769.06 Billion | 494.36 Billion | 367.98 Billion | 15.98 Billion | 233.24 Billion | 168.45 Billion |
| Net Income | 611.75 Billion | 394.16 Billion | 301.14 Billion | 7.94 Billion | 174.28 Billion | 124.12 Billion |
| Earnings Per Share Basic | 130.00 | 83.76 | 74.19 | 198.62 Thousand | 37.04 | 26.38 |
| Earnings Per Share Diluted | 130.00 | 83.76 | 74.19 | 198.62 Thousand | 37.04 | 26.38 |
| Weighted Average Shares Outstanding | 4.7 Billion | 4.7 Billion | 4.05 Billion | 40 Thousand | 4.7 Billion | 4.7 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.7 Billion | 4.7 Billion | 4.05 Billion | 40 Thousand | 4.7 Billion | 4.7 Billion |
| Gross Margin | 0.17 | 0.16 | 0.16 | 0.12 | 0.17 | 0.15 |
| EBIT Margin | 0.17 | 0.12 | 0.11 | 0.04 | 0.11 | 0.09 |
| Profit Margin | 0.11 | 0.10 | 0.10 | 0.00 | 0.06 | 0.05 |
| EBITDA | 953.94 Billion | 618.02 Billion | 532.13 Billion | 174.64 Billion | 287.46 Billion | 221.3 Billion |
| Earnings Before Tax Margin | 0.14 | 0.14 | 0.11 | 0.04 | 0.10 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1467.24 Billion | 1219.96 Billion | 1335.22 Billion | 5541.17 Billion | 1295.59 Billion | 1505.44 Billion |
| Cost of Revenue | 1186.06 Billion | 1023.86 Billion | 1093.48 Billion | 4577.81 Billion | 1093.78 Billion | 1220.18 Billion |
| Gross Profit | 281.17 Billion | 196.09 Billion | 241.74 Billion | 963.35 Billion | 201.8 Billion | 285.25 Billion |
| Operating Expenses | 79.45 Billion | 60.97 Billion | 82.43 Billion | 276.49 Billion | 92.44 Billion | 69.75 Billion |
| Selling, General and Administrative Expenses | 22.38 Billion | 82.29 Billion | 82.4 Billion | - | 104.35 Billion | 22.91 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 57.07 Billion | 21.31 Billion | -34.46 Million | 48.22 Billion | 11.9 Billion | 13.22 Billion |
| Cost and Expenses | 1265.52 Billion | 1084.84 Billion | 1175.91 Billion | 4854.3 Billion | 1186.22 Billion | 1289.94 Billion |
| Operating Income | 229.25 Billion | 135.12 Billion | 159.3 Billion | 686.86 Billion | 109.36 Billion | 232.17 Billion |
| Interest Expense | 9.6 Billion | 9.25 Billion | 9 Billion | 40.91 Billion | 6.5 Billion | 10.34 Billion |
| Income Tax Expense | 43.19 Billion | 26.5 Billion | 37.36 Billion | 143.55 Billion | 18.57 Billion | 45.68 Billion |
| Earnings before Tax | 222.16 Billion | 117.74 Billion | 166.2 Billion | 728.02 Billion | 107.73 Billion | 223.46 Billion |
| Net Income | 175 Billion | 103.66 Billion | 133.4 Billion | 611.75 Billion | 92.33 Billion | 173.55 Billion |
| Earnings Per Share Basic | 37.19 | 22.03 | 28.35 | - | 19.62 | 36.88 |
| Earnings Per Share Diluted | 37.19 | 22.03 | 28.35 | - | 19.62 | 36.88 |
| Weighted Average Shares Outstanding | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion | 4.7 Billion |
| Gross Margin | 0.19 | 0.16 | 0.18 | 0.17 | 0.16 | 0.19 |
| EBIT Margin | 0.16 | 0.16 | 0.16 | - | 0.12 | 0.16 |
| Profit Margin | 0.12 | 0.08 | 0.10 | 0.11 | 0.07 | 0.12 |
| EBITDA | 236.74 Billion | 195.42 Billion | 215.22 Billion | - | 158.25 Billion | 237.13 Billion |
| Earnings Before Tax Margin | 0.16 | 0.11 | 0.12 | 0.12 | 0.08 | 0.15 |
6349
JOHNPHARMA
GML
TRIDENT
ASMVF
MAHAPEXLTD